PPLC 2021: Updated results of a study investigating venetoclax combined with rituximab for treatment of relapsed chronic lymphocytic leukemia.
Home / Resource Library / Long term Follow up Solidifies Role of Fixed duration Venetoclax Plus Rituximab in Relapsed/Refractory CLL